ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 132 filers reported holding ALLAKOS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $91,990 | -91.0% | 19,006 | -84.4% | 0.00% | – |
Q4 2022 | $1,026,883 | +129.7% | 121,813 | -6.2% | 0.00% | – |
Q2 2022 | $447,000 | -13.4% | 129,910 | +153.6% | 0.00% | – |
Q4 2021 | $516,000 | -69.7% | 51,231 | +178.4% | 0.00% | -100.0% |
Q2 2021 | $1,701,000 | +2000.0% | 18,405 | +2328.1% | 0.00% | – |
Q1 2021 | $81,000 | -98.7% | 758 | -98.4% | 0.00% | -100.0% |
Q4 2020 | $6,210,000 | +101.2% | 48,866 | +32.7% | 0.00% | +100.0% |
Q3 2020 | $3,087,000 | +2256.5% | 36,827 | +1791.5% | 0.00% | – |
Q2 2020 | $131,000 | -44.0% | 1,947 | -20.8% | 0.00% | – |
Q4 2019 | $234,000 | +74.6% | 2,459 | +43.9% | 0.00% | – |
Q3 2019 | $134,000 | +112.7% | 1,709 | +17.1% | 0.00% | – |
Q2 2019 | $63,000 | +950.0% | 1,459 | +1136.4% | 0.00% | – |
Q4 2018 | $6,000 | +100.0% | 118 | +107.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 57 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |